# The Belgian SMART Study Evaluating the Use of Golimumab for Ulcerative Colitis

> **NCT02914717** · — · COMPLETED · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 100 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02914717
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-27
- **Primary completion:** 2016-12
- **Final completion:** 2018-05
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-06-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02914717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02914717, "The Belgian SMART Study Evaluating the Use of Golimumab for Ulcerative Colitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02914717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*